DABABNEH, HUSSAM MUSA SALEM
 Distribuzione geografica
Continente #
NA - Nord America 4.214
AS - Asia 3.731
EU - Europa 3.034
AF - Africa 346
SA - Sud America 173
OC - Oceania 11
AN - Antartide 1
Totale 11.510
Nazione #
US - Stati Uniti d'America 4.148
VN - Vietnam 1.190
SG - Singapore 1.020
CN - Cina 840
GB - Regno Unito 825
IT - Italia 470
DE - Germania 415
SE - Svezia 326
FR - Francia 224
HK - Hong Kong 217
RU - Federazione Russa 172
IN - India 170
TG - Togo 136
IE - Irlanda 133
BR - Brasile 121
NL - Olanda 107
ZA - Sudafrica 76
FI - Finlandia 66
UA - Ucraina 61
EE - Estonia 58
CI - Costa d'Avorio 53
JO - Giordania 52
CA - Canada 50
NG - Nigeria 45
BE - Belgio 39
JP - Giappone 38
BG - Bulgaria 28
TH - Thailandia 27
IR - Iran 23
AR - Argentina 22
PH - Filippine 19
BD - Bangladesh 18
CH - Svizzera 18
LT - Lituania 18
PL - Polonia 18
TR - Turchia 18
IQ - Iraq 17
TW - Taiwan 15
EC - Ecuador 12
ES - Italia 12
ID - Indonesia 12
PK - Pakistan 12
AT - Austria 11
AU - Australia 10
MX - Messico 10
RO - Romania 8
CZ - Repubblica Ceca 7
ET - Etiopia 7
GR - Grecia 7
SC - Seychelles 7
UZ - Uzbekistan 7
KR - Corea 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
LB - Libano 5
CL - Cile 4
MY - Malesia 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
GH - Ghana 3
KE - Kenya 3
SN - Senegal 3
AL - Albania 2
BF - Burkina Faso 2
CO - Colombia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
OM - Oman 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RW - Ruanda 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
Totale 11.510
Città #
Southend 705
Singapore 700
Ashburn 563
Chandler 486
Fairfield 284
Hong Kong 201
San Jose 201
Santa Clara 187
Dong Ket 180
Ho Chi Minh City 180
Hanoi 179
Wilmington 171
Houston 166
Seattle 162
Princeton 153
Lomé 136
Dublin 132
Ann Arbor 127
Beijing 121
Woodbridge 113
Cambridge 93
Nanjing 85
Boardman 79
Lauterbourg 72
Westminster 70
Padova 68
New York 57
Abidjan 53
Amman 52
Berlin 52
Medford 51
Jinan 50
Helsinki 49
Shenyang 47
Bremen 46
Los Angeles 46
Bologna 42
Abeokuta 41
Milan 41
London 39
Saint Petersburg 39
Brussels 38
Turin 38
Frankfurt am Main 37
Dearborn 35
Haiphong 34
Munich 33
Hebei 32
Tokyo 31
Dallas 30
Tianjin 28
Buffalo 27
Da Nang 27
Redondo Beach 27
Sofia 26
Nanchang 25
Guangzhou 23
Jacksonville 22
Florence 21
Mountain View 20
São Paulo 20
Toronto 20
Changsha 19
Basingstoke 18
Hangzhou 18
Falkenstein 17
Redwood City 17
San Diego 16
Turku 16
Haikou 15
Pune 14
Düsseldorf 13
Phoenix 13
Fuzhou 12
Rome 12
Biên Hòa 11
Falls Church 11
Montreal 11
Ningbo 11
Ottawa 11
Taiyuan 11
Warsaw 11
Yubileyny 11
Bexley 10
Hải Dương 10
Jiaxing 10
Mülheim 10
Olalla 10
Nuremberg 9
Stockholm 9
Taizhou 9
Torino 9
Kunming 8
Norwalk 8
Shanghai 8
Shenzhen 8
Zanjan 8
Zhengzhou 8
Andover 7
Chengdu 7
Totale 7.349
Nome #
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer 283
Sex-related penile fracture with complete urethral rupture: A case report and review of the literature 251
ACCURACY OF PET/CT WITH 11-C-CHOLINE IN THE RESTAGING OF RECURRENT PROSTATE CANCER PATIENTS WITH A SINGLE LESION AT BONE SCINTIGRAPHY 243
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 231
Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes 214
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 210
MRI DISPLAYS THE PROSTATIC CANCER ANATOMY AND IMPROVES THE BUNDLES MANAGEMENT BEFORE ROBOT ASSISTED RADICAL PROSTATECTOMY 208
Can testis-sparing surgery for small testicular masses be considered a valid alternative to radical orchiectomy? A prospective single-center study 206
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 206
The impact of a structured intensive modular training in the learning curve of robot assisted radical prostatectomy. 199
Holmium laser prostatectomy in a tertiary Italian center: A prospective cost analysis in comparison with bipolar TURP and open prostatectomy 197
Fibrotic Adhesive Toxic-fat (F.A.T.): the association of fibrotic and adhesive perirenal fat with peri-operative outcomes of robot-assisted par tial nephrectomy (RAPN) 195
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and midterm follow-up 193
ACCURATEZZA DELLA TC/PETCON 11-C-COLINA NELLA RISTADIAZIONE DEI PAZIENTI CON NEOPLASIA PROSTATICA RECIDIVA CON UNA SINGOLA LESIONE ALLA SCINTIGRAFIA OSSEA 193
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 192
"In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients 192
INFLUENZA DEL PSA TOTALE, DELLA PSA VELOCITY E DEL PSA DOUBLING TIME SULLA DETECTION RATE DELLA 11C COLINA PET/CT IN PAZIENTE CON RIPRESA BIOCHIMICA DOPO PROSTATECTOMIA RADICALE 189
COMPLICANZE E MORTALITÀ PERIOPERATORIE DELLA CISTECTOMIA RADICALE: ANALISI RETROSPETTIVA UTILIZZANDO UNA CLASSIFICAZIONE STANDARDIZZATA 182
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates 182
DUPLICE ENUCLEORESEZIONE RENALE ROBOTICA CON ACCESSO RETROPERITONEALE IN PAZIENTE CON PREGRESSA CHIRURGIA ADDOMINALE, TROMBOCITOPENIA CRONICA E CIRROSI EPATICA 177
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 176
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 176
NEFRECTOMIA PARZIALE ROBOTICA CON APPROCCIO RETROPERITONEALE A QUATTRO BRACCIA 173
SOPRAVVIVENZA CANCRO SPECIFICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE E MALATTIA AGGRESSIVA ALL’ESAME ISTOLOGICO DEFINITIVO. 172
ElectRomagnetic synchronized real-time system for MRI-TRUS fusion targeted biopsy of prostate (Toshiba Aplio 500Tm) in a heterogeneous pa tients cohort: results and compa rison with systematic biopsy 168
Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study. 168
PREOPERATIVE MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING AND NEUROVASCULAR BUNDLE MANAGEMENT: SURGICAL PLAN CHANGE IN COURSE OF Robot-assISTED RADICAL PROSTATECTOMY 167
Patterns of positive surgical margins after surgery in prostate cancer pa tients and their association with clinical recurrence 167
INFLUENZA DEL PSA TOTALE, DELLA PSA VELOCITY E DEL PSA DOUBLING TIME SULLA DETECTION RATE DELLA 11C-COLINA PET/CT IN PAZIENTE CON RIPRESA BIOCHIMICA DOPO PROSTATECTOMIA RADICALE 166
POSSIAMO INCLUDERE NELLA SORVEGLIANZA ATTIVA PER NEOPLASIA PROSTATICA, PAZIENTI CON CGS 3+4 IN UN UNICO PRELIEVO BIOPTICO? RISULTATI A MEDIO TERMINE DI UN SINGOLO CENTRO DOPO REVISIONE ISTOLOGICA SISTEMATICA DEI PRELIEVI BIOPTICI E DEI REPERTI OPERATORI 163
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 162
QUAL È L'IMPATTO DEI MARGINI POSITIVI SULLA RIPRESA BIOCHIMICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE PER CARCINOMA PROSTATICO? 162
Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. 161
THE VALUE OF HISTOLOGICAL REVISION OF BIOPSY CORES IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: COMPARISON WITH SURGICAL SPECIMENS AFTER RADICAL PROSTATECTOMY AND CLINICAL FOLLOW-UP 160
Survival, continence and potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes 160
The role of standard biopsy during an MRI-TRUS fusion targeted biopsy: A two cohort study in previous negative biopsy and active surveillance patients 160
RIPARAZIONE DI LESIONE DEL RETTO IN CORSO DI PROSTATECTOMIA RADICALE ROBOTICA UTILIZZANDO UN INNESTO PERITONEALE 159
Small Renal Masses Managed With Active Surveillance: Predictors of Tumor Growth Rate After Long-Term Follow-Up. 159
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes. 158
Role of testis sparing surgery in the conservative management of small testicular masses: oncological and functional perspectives. 157
IMPATTO ECONOMICO DELLA TERAPIA CHIRURGICA A CIELO APERTO ED ENDOSCOPICA PER L’IPERTROFIA PROSTATICA BENIGNA: ANALISI E CONFRONTO DEI COSTI SOSTENUTI NEL 2015 DA UN CENTRO DI TERZO LIVELLO 156
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma 156
LYMPH NODE DENSITY IN NODE-POSITIVE PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 155
MAGNETIC RESONANCE/ULTR ASOUND-GUIDED FUSION PROSTATE BIOPSY: CANCER DETECTION RATE WITHIN CONSECUTIVE CORES TAKEN 154
PREDICTING CANCER- SPECIFIC AND OTHER-CAUSE MORTALITY IN ELDERLY PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER: A COMPETING RISK ANALYSIS 153
LAPAROSCOPIC AND ROBOTIC URETERAL STENOSIS REPAIR: A MULTI-INSTITUTIONAL EXPERIENCE WITH A LONG-TERM FOLLOW UP 152
State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer 151
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 151
The value of histological revision of biopsy cores in patients suitable for active surveillance: comparison with surgical specimens after radical prostatectomy and clinical follow-up. 149
V24: A new single barbed bidirectional suture (Filbloc, Assut SPA) for posterior muscolofascial reconstruction and knotless urethrovesical anastomosis during RARP 149
LINFADENECTOMIA STANDARD VS ESTESA 148
ROBOT-ASSISTED PARTIAL URETERECTOMY WITH END-TO-END ANASTOMOSIS FOR IATROGEN STENOSIS OF THE PROXIMAL URETER 146
RISULTATI MORFOLOGICI E FUNZIONALI DELLE NEOVESCICHE ILEALI ORTOTOPICHE:3 TECNICHE A CONFRONTO 146
THE PROGNOSTIC IMPACT OF TUMOR SIZE ON CANCER-SPECIFIC AND OVERALL SURVIVAL AMONG PATIENTS WITH PATHOLOGIC T3A RENAL CELL CARCINOMA 145
INFLUENZA DELLA DEPRIVAZIONE ORMONALE SUL RISULTATO DELLA 11CCOLINA-PET/CT IN PAZIENTI CON NEOPLASIA PROSTATICA 143
VALIDATION OF PRIAS ACTIVE SURVEILLANCE CRITERIA IN PATIENTS SUBMITED TO RADICAL PROSTATECTOMY 141
RUOLO DELLA TOMOGRAFIA COMPUTERIZZATA MULTIFASICA (TC) NEL MANAGEMENT CLINICO DELLE PICCOLE MASSE RENALI (SRMS). 138
PROSTATECTOMIA ROBOTICA NERVE-SPARING: RUOLO DELLA RISONANZA MAGNETICA PREOPERATORIA 137
PREOPERATIVE 11C-CHOLINE PET-CT IN INTERMEDIATE, HIGH RISK AND VERY HIGH RISK PROSTATE CANCER PATIENTS: IS THERE STILL ANY ROOM LEFT FOR IT? 135
THE IMPACT OF PELVIC LYMPH-NODE DISSECTION AND OF ITS EXTENT ON BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICAL N0 OR NX AT INTERMEDIATE AND HIGH RISK OF LYMPH-NODE INVASION 133
SURVIVAL AND FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: BIFECTA ACHIEVEMENT IN PATIENTS AGED ≥ 75 YEARS 132
INFLUENZA DELLA DEPRIVAZIONE ORMONALE SUL RISULTATO DELLA 11C COLINA PET/CT IN PAZIENTI CON NEOPLASIA PROSTATICA 131
CAN TESTIS-SPARING SURGERY BE A VALID ALTERNATIVE TO RADICAL ORCHIECTOMY IN SELECTED CASES? A PROSPECTIVE STUDY 130
THE IMPACT OF PATHOLOGIC FEATURES ON CANCER SPECIFIC SURVIVAL OF PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER 129
THE IMPACT OF PELVIC LYMPH-NODE DISSECTION AND OF ITS EXTENT ON BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICAL N0 OR NX AT INTERMEDIATE AND HIGH RISK OF LYMPH-NODE INVASION 128
RUOLO DELLA LYMPH-NODE DENSITY NELL’OUTCOME ONCOLOGICO DEI PAZIENTI CON METASTASI LINFONODALI DA CARCINOMA prostatico SOTTOPOSTI A PROSTATECTOMIA RADICALE E LINFADENECTOMIA PELVICA 125
QUAL'E' L'IMPATTO DEI MARGINI POSITIVI SULLA RIPRESA BIOCHIMICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE PER CARCINOMA 122
Small renal masses initially managed using active surveillance: results from a retrospective study with long-term follow-up. 114
V32: Robot-assisted partial cystectomy for the treatment of urachus acinar adenocarcinoma 113
PATIENTS WITH LYMPH-NODE METASTASIS AFTER RADICAL PROSTATECTOMY AND PELVIC LYMPH-NODE DISSECTION ARE NOT ALL SUBJECT TO THE SAME RISK OF CANCER DEATH: IDENTIFYING DIFFERENT RISKCATEGORY ACCORDING TO THE NUMBER OF POSITIVE NODES AND GLEASON SCORE 103
PRESERVATION OF INTERNAL VESICAL SPHINCTER AND PROXIMAL URETHRA DURINGRADICAL PROSTATECTOMY IMPROVES EARLIERCONTINENCE RECOVERY 97
Feasibility and setting of single docking HUGO RAS robot-assisted nephroureterectomy: first European experience 50
Totale 11.749
Categoria #
all - tutte 27.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021474 0 0 0 0 0 0 0 0 0 24 18 432
2021/20221.370 204 45 64 59 137 68 21 83 35 107 302 245
2022/20231.807 194 357 120 221 112 119 46 88 330 63 112 45
2023/2024452 41 64 15 48 48 90 45 34 5 32 11 19
2024/20251.597 61 251 123 121 251 101 86 65 8 158 49 323
2025/20263.280 332 189 284 202 444 197 329 94 910 299 0 0
Totale 11.749